desonide - Medical Dictionary

Home | desonide - Medical Dictionary |


desonide		A nonfluorinated corticosteroid anti-inflammatory agent used topically for dermatoses. [ Books \| Images \| Discussion groups ]

Additional comments : (Prednacinolone, Desocort, Desone, Desowen, Locapred, Locatop, Tridesilon) Articles Direct injection LC/ESI-MS horse urine analysis for the quantification and identification of threshold substances for doping control. I. Determination of hydrocortisone. Authors: Vonaparti A, Lyris E, Panderi I, Koupparis M, Georgakopoulos C Journal: J Mass Spectrom Desonide foam: a review. Authors: Parish D, Scheinfeld N Journal: Drugs Today (Barc) Desonide gel. Authors: Scheinfeld NS, Parish DH Journal: Skinmed A novel hydrogel vehicle formulated for the treatment of atopic dermatitis. Authors: Kircik L, Del Rosso J Journal: J Drugs Dermatol Tega-dermabrasion. Authors: O'Connor JJ, Vasudevan A Journal: Anesthesiology Ketoconazole gel 2% in the treatment of moderate to severe seborrheic dermatitis. Authors: Swinyer LJ, Decroix J, Langner A, Quiring JN, Blockhuys S Journal: Cutis Efficacy of desonide 0.05% cream and lotion in steroid-responsive dermatoses in Indian patients: a post-marketing surveillance study. Authors: Bhankharia DA, Sanjana PH Journal: Indian J Dermatol Venereol Leprol Effect of desonide hydrogel 0.05% on the hypothalamic-pituitary-adrenal axis in pediatric subjects with moderate to severe atopic dermatitis. Authors: Eichenfield LF, Basu S, Calvarese B, Trancik RJ Journal: Pediatr Dermatol Periorbital cutaneous neonatal lupus. Authors: Cooper RM, Butler DF, Ghali F, Grimwood RE Journal: Skinmed Safety and efficacy of desonide hydrogel 0.05% in pediatric subjects with atopic dermatitis. Authors: Hebert AA, Cook-Bolden FE, Basu S, Calvarese B, Trancik RJ, Journal: J Drugs Dermatol Verdeso (desonide) Foam, 0.05%. Authors: Abramovits W, Gupta AK Journal: Skinmed Photochemistry of Desonide, a Non-fluorinated Steroidal Anti-inflammatory Drug. Authors: Iqbal J, Husain A, Gupta A Journal: Chem Pharm Bull (Tokyo) Erythematous scaling eyelids: patient history, exposure to allergens and irritants are keys to diagnosis. Authors: Graves JE, Brodell RT Journal: Postgrad Med Rapid resolution of a common problem. Authors: Tauscher A, Paniker PU Journal: Am J Med [Connubial contact dermatitis to an inhaled corticosteroid] Authors: Raison-Peyron N, Co Minh HB, Vidal-Mazuy A, Guilhou JJ, Guillot B Journal: Ann Dermatol Venereol Corneofungimetry bioassay on Malassezia spp. under ketoconazole and desonide influences. Authors: Piérard-Franchimont C, Vroome V, Cauwenbergh G, Piérard GE Journal: Skin Pharmacol Physiol Comparison of the analysis of corticosteroids using different techniques. Authors: Pujos E, Flament-Waton MM, Paisse O, Grenier-Loustalot MF Journal: Anal Bioanal Chem Seborrheic dermatitis. Authors: Scheinfeld NS Journal: Skinmed Steroid therapy altered serum levels of CCL2 and CCL5 chemokines in multiple sclerosis patients during relapse. Authors: Bartosik-Psujek H, Stelmasiak Z Journal: Eur Neurol Developments in ocular allergy. Authors: Chambless SL, Trocme S Journal: Curr Opin Allergy Clin Immunol Two case reports of cutaneous adverse reactions following hepatitis B vaccine: lichen planus and granuloma annulare. Authors: Criado PR, de Oliveira Ramos R, Vasconcellos C, Jardim Criado RF, Valente NY Journal: J Eur Acad Dermatol Venereol Overview on desonide 0.05%: a clinical safety profile. Authors: Wong VK, Fuchs B, Lebwohl M Journal: J Drugs Dermatol Evaluation of cross-reactivity between budesonide and desonide. Authors: Foti C, Cassano N, Vena GA Journal: Contact Dermatitis Efficacy, cutaneous tolerance and cosmetic acceptability of desonide 0.05% lotion (Desowen) versus vehicle in the short-term treatment of facial atopic or seborrhoeic dermatitis. Authors: Freeman S, Howard A, Foley P, Rosen R, Wood G, See JA, Gray S Journal: Australas J Dermatol A double-blind placebo-controlled study of ketoconazole + desonide gel combination in the treatment of facial seborrheic dermatitis. Authors: Piérard-Franchimont C, Piérard GE Journal: Dermatology Efficacy and safety of desonide phosphate for the treatment of allergic conjunctivitis. Authors: Leonardi A, Papa V, Milazzo G, Secchi AG Journal: Cornea [Comparative study of efficacy and effect on plasma cortisol levels of micronised desonide cream 0.1 p. 100 versus betamethasone dipropionate cream 0.05 p. 100 In the treatment of childhood atopic dermatitis] Authors: Lebrun-Vignes B, Legrain V, Amoric J, Taïeb A Journal: Ann Dermatol Venereol Topical corticosteroid-induced acne. Three treatment strategies to break the 'addiction' cycle. Authors: Brodell RT, O'Brien MJ Journal: Postgrad Med Contact puzzle: Worsening of a recurrent facial eruption despite treatment. Diagnosis: allergic contact dermatitis caused by desonide. Authors: Garner LA, Cruz PD Journal: Am J Contact Dermat Toddler-to-mother transmission of varicella-vaccine virus: how bad is that? Authors: Long SS Journal: J Pediatr Effect of desonide ointment, 0.05%, on the hypothalamic-pituitary-adrenal axis of children with atopic dermatitis. Authors: Lucky AW, Grote GD, Williams JL, Tuley MR, Czernielewski JM, Dolak TM, Herndon JH, Baker MD Journal: Cutis Allergic contact dermatitis from propyl gallate in desonide cream (Locapred). Authors: Hernández N, Assier-Bonnet H, Terki N, Revuz J Journal: Contact Dermatitis On-line post-column photochemical derivatization in liquid chromatographic--diode-array detection analysis of binary drug mixtures. Authors: Di Pietra AM, Andrisano V, Gotti R, Cavrini V Journal: J Pharm Biomed Anal Laser resurfacing in pigmented skin. Authors: Ho C, Nguyen Q, Lowe NJ, Griffin ME, Lask G Journal: Dermatol Surg Multicenter trial for long-term safety and efficacy comparison of 0.05% desonide and 1% hydrocortisone ointments in the treatment of atopic dermatitis in pediatric patients. Authors: Jorizzo J, Levy M, Lucky A, Shavin J, Goldberg G, Dunlap F, Hinds A, Strelka L, Baker M, Tuley M Journal: J Am Acad Dermatol Local steroid therapy and bacterial skin flora in atopic dermatitis. Authors: Stalder JF, Fleury M, Sourisse M, Rostin M, Pheline F, Litoux P Journal: Br J Dermatol The identification of related substances in triamcinolone acetonide by means of high-performance liquid chromatography with diode array detector and mass spectrometry. Authors: Cavina G, Alimenti R, Gallinella B, Valvo L Journal: J Pharm Biomed Anal Comparative effects of two topical antiseptics (chlorhexidine vs KMn04) on bacterial skin flora in atopic dermatitis. Authors: Stalder JF, Fleury M, Sourisse M, Allavoine T, Chalamet C, Brosset P, Litoux P Journal: Acta Derm Venereol Suppl (Stockh) Quantification of skin-colour changes induced by topical corticosteroid preparations using the Minolta Chroma Meter. Authors: Queille-Roussel C, Poncet M, Schaefer H Journal: Br J Dermatol Contact dermatitis due to budesonide. Authors: Piraccini BM, Bardazzi F, Morelli R, Tosti A Journal: Contact Dermatitis Allergic contact dermatitis from topical corticosteroids. Authors: Rivara G, Tomb RR, Foussereau J Journal: Contact Dermatitis Topical metronidazole for severe and recalcitrant rosacea: a prospective open trial. Authors: Lowe NJ, Henderson T, Millikan LE, Smith S, Turk K, Parker F Journal: Cutis Development of glucocorticosteroids with enhanced ratio between topical and systemic effects. Authors: Thalén A, Brattsand R, Andersson PH Journal: Acta Derm Venereol Suppl (Stockh) [Atopic dermatitis and staphylococcal infection] Authors: Stalder JF, Sourisse M Journal: Ann Dermatol Venereol Potency ranking of two new topical corticosteroid creams containing 0.1% desonide or 0.05% halometasone utilising the human skin blanching assay. Authors: Meyer E, Smith EW, Haigh JM, Kanfer I Journal: Arzneimittelforschung Identification and analysis of a degradation product of the glucocorticoid desonide in ointment. Authors: Nguyen TT, Kringstad R, Aasen AJ, Rasmussen KE Journal: Acta Chem Scand B Comparison of the cutaneous/systemic antiinflammatory activity ratios for desonide and hydrocortisone in various experimental models. Authors: Tarayre JP, Aliaga M, Barbara M, Ballester R, Tisné-Versailles J, Couzinier JP Journal: Arzneimittelforschung Control of the bioavailability of a topical steroid; comparison of desonide creams 0.05% and 0.1% by vasoconstrictor studies and clinical trials. Authors: Barry BW, Fyrand O, Woodford R, Ulshagen K, Hogstad G Journal: Clin Exp Dermatol Effect of structural alterations on the biotransformation rate of glucocorticosteroids in rat and human liver. Authors: Andersson P, Lihné M, Thalén A, Ryrfeldt A Journal: Xenobiotica Use of extraction columns for the isolation of desonide and parabens from creams and ointments for high-performance liquid chromatographic analysis. Authors: Nguyen TT, Kringstad R, Rasmussen KE Journal: J Chromatogr Hydrocortisone 17-butyrate (Locoid) 0.1% fatty cream versus desonide (Apolar) 0.1% ointment in the treatment of patients suffering from atopic dermatitis. Authors: Rajka G, Verjans HL Journal: J Int Med Res Pharmacological study of cantharidin-induced ear inflammation in mice. Authors: Tarayre JP, Aliaga M, Barbara M, Villanova G, Caillol V, Lauressergues H Journal: J Pharmacol Methods Pharmacological comparison of the immune and non-immune inflammations induced by picryl chloride and oxazolone in mice. Authors: Tarayre JP, Aliaga M, Villanova G, Barbara M, Caillol V, Bru M, Lauressergues H Journal: Arch Int Pharmacodyn Ther Efficacy versus systemic effects of six topical steroids in the treatment of atopic dermatitis of childhood. Authors: Queille C, Pommarede R, Saurat JH Journal: Pediatr Dermatol [Comparative antiallergic and anti-inflammatory action of F1865, mepyramine maleate, desonide and disodium cromoglycate after cutaneous administration] Authors: Tarayre JP, Aliaga M, Villanova G, Barbara M, Bru M, Caillol V, Lauressergues H Journal: J Pharmacol Contact dermatitis to desonide. Authors: Sturtz RP, Rau RC Journal: Arch Dermatol Metabolic pathways of the topical glucocorticoid budesonide in man. Authors: Edsbäcker S, Jönsson S, Lindberg C, Ryrfeldt A, Thalén A Journal: Drug Metab Dispos [Non-halogenated glucocorticoids. A clinical comparison between budesonide 0,025% ointment and desonide 0,1% ointment in psoriasis] Authors: Granholt A, Malmsten LA Journal: Tidsskr Nor Laegeforen Modulation by various locally applied anti-inflammatory and anti-allergic compounds of the immune and non-immune inflammation induced by picryl chloride in mice. Authors: Tarayre JP, Lauressergues H Journal: Agents Actions Enhanced percutaneous penetration with 1-dodecylazacycloheptan-2-one. Authors: Stoughton RB Journal: Arch Dermatol Clinical comparison of alclometasone dipropionate and desonide ointments (0.05%) in the management of psoriasis. Authors: Frost P, Horwitz SN Journal: J Int Med Res GLC analysis of hydrocortisone, triamcinolone acetonide, and desonide in culture media of mouse and human dermal fibroblasts using flame-ionization detection. Authors: Au DS, Runikis JO, Abbott FS, Burton RW Journal: J Pharm Sci Comparison of the effect of phenylbutazone, desonide and cyclophosphamide on four types of experimental pleurisy. Authors: Tarayre JP, Lauressergues H Journal: J Pharm Pharmacol Steroid problems. Authors: Britto JF Journal: Int J Dermatol Comparison of the effects of a non-steroidal anti-inflammatory agent, an immunosuppressive, a corticosteroid and an immunomodulator on various immunological and non-immunological inflammatory experimental models. Authors: Tarayre JP, Lauressergues H Journal: Arch Int Pharmacodyn Ther Perioral dermatitis: a reappraisal. Authors: Cochran RE, Thomson J Journal: Clin Exp Dermatol Action of various drugs with anti-inflammatory or anti-rheumatic properties on pleurisy due to Bordetella pertussis hypersensitivity in the rat. Authors: Tarayre JP, Delhon A, Lauressergues H Journal: Pharmacology Action of phenylbutazone, cyclophosphamide and prednacinolone on pleurisy due to Bordetella pertussis hypersensitivity in the rat. Authors: Tarayre JP, Lauressergues H Journal: Arch Int Pharmacodyn Ther Growth rate of cultured human fibroblasts increased by glucocorticoids. Authors: Runikis JO, McLean DI, Stewart WD Journal: J Invest Dermatol [Clinical test with Apolar cream and Calmuril-hydrocortisone cream in contact dermatitis and atopic dermatitis] Authors: Gip L Journal: Tidsskr Nor Laegeforen Contact dermatitis due to multiple corticosteroid creams. Authors: Coskey RJ Journal: Arch Dermatol Corticosteroid-induced dermal atrophy in the rat. Authors: Young JM, Yoxall BE, Wagner BM Journal: J Invest Dermatol [Nonabsorption of iodochlorohydroxyquinoline after topical vaginal administration in Rhesus macaca] Authors: Frova C, Rigamonti G Journal: Boll Chim Farm [Clinical study of a new preparation in the treatment of anorectal varices] Authors: Pollinzi V, Sortini A, Rigobello P, Sala P Journal: Minerva Chir Bioavailability and activity of topical corticosteroids from a novel drug delivery system, the aerosol quick-break foam. Authors: Woodford R, Barry BW Journal: J Pharm Sci Clinical comparison of desonide cream with fluocinonide cream in steroid-responsive dermatologic disorders. Authors: Barsky S Journal: Cutis Dose titration of steroidal and non-steroidal topical anti-inflammatory agents. Authors: Sanen FJ, Van Scott E, Bayard S Journal: Int J Clin Pharmacol Biopharm Letter: Preliminary trial of desonide, a new topical corticosteroid. Authors: MacDonald A, Fry L Journal: Br J Dermatol Letter: Evaluation of desonide cream. Authors: Van Scott EJ Journal: JAMA A clinical evaluation of 0.05 per cent desonide cream. A new nonfluorinated topical corticosteroid. Authors: Gentry WC, Rosenberg EW, Goltz RW Journal: Arch Dermatol Desonide, a potent nonfluorinated topical steroid, vasoconstriction assay and clinical trial. Authors: Smith EB, Gregory JF, Bartruff JK Journal: South Med J The treatment of common dermatoses with topically applied 0.05 per cent desonide cream. A paired-comparison clinical study. Authors: Reque PG Journal: J Med Assoc State Ala Clinical comparison of desonide cream with betamethasone valerate cream. A double-blind randomized study. Authors: Bluefarb SM Journal: Int J Dermatol The physical, animal and human pharmacologic, and toxicologic properties of desonide, a new, topically active, antiinflammatory steroid. Authors: Phillips BM, Sanen FJ, Leeling JL, Hammes TL, Hartnagel RE, Sancilio LF, Lorenzetti OJ, Kraus PJ Journal: Toxicol Appl Pharmacol

Back